(Q37694061)

22 August 2017

1 reference

title

RANK/RANKL/OPG role in distraction osteogenesis (English)

1 reference

22 August 2017

Mario Pérez-Sayáns

1

1 reference

22 August 2017

José Manuel Somoza-Martín

2

1 reference

22 August 2017

Francisco Barros-Angueira

3

1 reference

22 August 2017

José Manuel Gándara Rey

4

1 reference

22 August 2017

Abel García-García

5

1 reference

22 August 2017

publication date

16 February 2010

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

22 August 2017

published in

1 reference

22 August 2017

volume

109

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

679-686

1 reference

Lengthening the Human Mandible by Gradual Distraction

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Osteogenic alveolar distraction: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

[The molecular biology of distraction osteogenesis]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Modeling the interactions between osteoblast and osteoclast activities in bone remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Minireview: the OPG/RANKL/RANK system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Biology of RANK, RANKL, and osteoprotegerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Functions of RANKL/RANK/OPG in bone modeling and remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

The RANKL/RANK/OPG pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Osteoclast differentiation and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Molecular control of bone remodeling and osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Localization of osteoprotegerin (OPG) on bone surfaces and cement lines in rat tibia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

The cell and molecular biology of fracture healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Histologic study of the cellular events during rat mandibular distraction osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Expression of bone matrix proteins mRNA during distraction osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Mandibular lengthening by gradual distraction. Preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Rat Mandibular Distraction Osteogenesis: II. Molecular Analysis of Transforming Growth Factor Beta-1 and Osteocalcin Gene Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

The molecular biology of distraction osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Expression of angiogenic factors during distraction osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Stimulation of Fos- and Jun-related genes during distraction osteogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Temporal and spatial expression of osteoprotegerin and receptor activator of nuclear factor -kappaB ligand during mandibular distraction in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Role of full-length osteoprotegerin in tumor cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Novel and selective small molecule stimulators of osteoprotegerin expression inhibit bone resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Membranous bone lengthening: a serial histological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

Distraction osteogenesis and its application to the midface and bony orbit in craniosynostosis syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.042

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRIPLEO.2009.10.042

1 reference

22 August 2017

1 reference